Pegaptanib sodium.
Fine
Stuart L
SL
Martin
Daniel F
DF
Kirkpatrick
Peter
P
D052157:Aptamers, Nucleotide; D004311:Double-Blind Method; D006801:Humans; D008268:Macular Degeneration / Q000188:drug therapy* / Q000517:prevention & control; D009841:Oligonucleotides / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D016896:Treatment Outcome; D042461:Vascular Endothelial Growth Factor A / Q000187:drug effects
D052157:Aptamers, Nucleotide; D009841:Oligonucleotides; D042461:Vascular Endothelial Growth Factor A; C495058:pegaptanib